Human Igg4 S228P Monoclonal Antibody Against Factor Xi And Activated Factor Xi

2 trials 1 recruiting

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

1 Recruiting

1 Completed trials

1 Sponsors

7 Countries

Phase III

Phase II

Phase III: 1 Phase II: 1

Sponsors using this IMP

Regeneron Pharmaceuticals Inc. 2

All trials

2 total

REGN7508 versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults. Recruiting

2025-520478-20-00 Phase III 6 countries Regeneron Pharmaceuticals Inc.
A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally In… Ended

2023-508603-21-00 Phase II 3 countries Regeneron Pharmaceuticals Inc.

Showing 1–2 of 2 trials

← All drugs A–Z